Categories U.S. Markets News
Pelosi in the lead for Speaker job as tech, healthcare stocks jump on midterm results
It was a bull run in the US market on Wednesday with the results of US midterm elections meeting expectations. Democrats won the House of Representatives, while Republicans strengthened their hold of the Senate, in what would turn out to be quite a situation in Washington.
The technology and healthcare stocks inched 1.5% higher on the news, as expectations of gridlocked government not being able to pass restrictions and related regulation came to the foreground.
Investors were quick to buy back into the market after the expected results, especially after a disastrous October.
An hour after the opening bell, Dow Jones Industrial Average was up 142.47 points, while the S&P 500 was up 21.30 points. The Nasdaq Composite gained 87.50 points.
After the October selloff, S&P 500 is still 5% below its all-time high. Other concerns regarding international foreign policy and trade war fears could be a few reasons for this.
Financial stocks, which where among the biggest gainers of the Trump administration, slipped 0.27% after bank stocks fell 0.52%.
The race for speaker
Many Democrats will soon be contesting for the top role in the House of Representatives, but 78-year-old San Francisco liberal Nancy Pelosi could be the first choice.
Minority leader Pelosi has already made it abundantly clear that she wants the job. She previously held the same position, that too as the first woman speaker, from 2007 to 2011.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company